Clinical trial
Budesonide in Treating Former and Current Smokers With Bronchial Dysplasia
NCT00005880 · British Columbia Cancer Agency, Other · Completed
Key facts
| NCT number | NCT00005880 |
|---|---|
| Title | Budesonide in Treating Former and Current Smokers With Bronchial Dysplasia |
| Official title | A Phase II Trial of Inhaled Budesonide (Pulmicort Turbuhaler) in Persons With Dysplasia of the Bronchial Epithelium |
| Lead sponsor | British Columbia Cancer Agency, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lung Cancer |
| Intervention type | Drug |
| Interventions | budesonide |
| Start date | Jul 1, 2000 |
| First posted | Feb 25, 2004 |
| Last update posted | Jul 24, 2008 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: